Ventas, Inc. (NYSE:VTR – Get Free Report) has been given an average rating of “Moderate Buy” by the nineteen analysts that are presently covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $97.5556.
A number of research analysts have recently commented on the stock. Scotiabank dropped their price objective on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Barclays initiated coverage on shares of Ventas in a report on Tuesday, July 7th. They issued an “equal weight” rating and a $99.00 target price for the company. Royal Bank Of Canada upped their price target on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. Wells Fargo & Company increased their price target on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Finally, Raymond James Financial began coverage on shares of Ventas in a report on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 price target on the stock.
Read Our Latest Stock Report on VTR
Insider Buying and Selling at Ventas
Institutional Trading of Ventas
Institutional investors have recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in Ventas by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock valued at $5,876,856,000 after buying an additional 2,349,176 shares during the period. State Street Corp lifted its position in Ventas by 2.5% during the fourth quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock valued at $2,309,234,000 after buying an additional 735,620 shares in the last quarter. Geode Capital Management LLC grew its stake in Ventas by 3.8% during the fourth quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock worth $1,001,447,000 after buying an additional 475,633 shares during the period. Price T Rowe Associates Inc. MD grew its stake in Ventas by 27.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock worth $710,060,000 after buying an additional 2,000,341 shares during the period. Finally, Capital World Investors acquired a new stake in shares of Ventas in the fourth quarter worth $594,116,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.
Ventas Stock Down 0.3%
Shares of NYSE:VTR opened at $92.22 on Friday. The stock’s 50-day moving average price is $89.32 and its two-hundred day moving average price is $86.05. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. Ventas has a 12-month low of $66.38 and a 12-month high of $101.60. The firm has a market cap of $47.30 billion, a price-to-earnings ratio of 170.78, a PEG ratio of 2.14 and a beta of 0.69.
Ventas Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, July 16th. Investors of record on Tuesday, June 30th were given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend was Tuesday, June 30th. Ventas’s dividend payout ratio (DPR) is 385.19%.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Recommended Stories
- Five stocks we like better than Ventas
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
